422 related articles for article (PubMed ID: 10556937)
1. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Huang YT; Hwang JJ; Lee PP; Ke FC; Huang JH; Huang CJ; Kandaswami C; Middleton E; Lee MT
Br J Pharmacol; 1999 Nov; 128(5):999-1010. PubMed ID: 10556937
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
3. Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells.
Lee LT; Huang YT; Hwang JJ; Lee AY; Ke FC; Huang CJ; Kandaswami C; Lee PP; Lee MT
Biochem Pharmacol; 2004 Jun; 67(11):2103-14. PubMed ID: 15135307
[TBL] [Abstract][Full Text] [Related]
4. Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells.
Lin YS; Tsai PH; Kandaswami CC; Cheng CH; Ke FC; Lee PP; Hwang JJ; Lee MT
Cancer Sci; 2011 Oct; 102(10):1829-39. PubMed ID: 21752154
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells.
Huang YT; Hwang JJ; Lee LT; Liebow C; Lee PP; Ke FC; Lo TB; Schally AV; Lee MT
Int J Cancer; 2002 Jun; 99(4):505-13. PubMed ID: 11992539
[TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma.
Nelson JM; Fry DW
Exp Cell Res; 1997 Jun; 233(2):383-90. PubMed ID: 9194500
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
9. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells.
Yoshida J; Ishibashi T; Yang M; Nishio M
Life Sci; 2010 Jan; 86(3-4):124-32. PubMed ID: 19951711
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
Gulli LF; Palmer KC; Chen YQ; Reddy KB
Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
Thompson AM; Murray DK; Elliott WL; Fry DW; Nelson JA; Showalter HD; Roberts BJ; Vincent PW; Denny WA
J Med Chem; 1997 Nov; 40(24):3915-25. PubMed ID: 9397172
[TBL] [Abstract][Full Text] [Related]
12. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960
[TBL] [Abstract][Full Text] [Related]
13. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
14. Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor.
Yoshida J; Ishibashi T; Nishio M
Cancer Res; 2001 Aug; 61(16):6151-7. PubMed ID: 11507066
[TBL] [Abstract][Full Text] [Related]
15. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
Buss JE; Chouvet C; Gill GN
J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
[TBL] [Abstract][Full Text] [Related]
16. Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
Lichtner RB; Menrad A; Sommer A; Klar U; Schneider MR
Cancer Res; 2001 Aug; 61(15):5790-5. PubMed ID: 11479217
[TBL] [Abstract][Full Text] [Related]
17. Impact of flavonoids on matrix metalloproteinase secretion and invadopodia formation in highly invasive A431-III cancer cells.
Lin YC; Tsai PH; Lin CY; Cheng CH; Lin TH; Lee KP; Huang KY; Chen SH; Hwang JJ; Kandaswami CC; Lee MT
PLoS One; 2013; 8(8):e71903. PubMed ID: 23991004
[TBL] [Abstract][Full Text] [Related]
18. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation.
Schmidt-Ullrich RK; Mikkelsen RB; Dent P; Todd DG; Valerie K; Kavanagh BD; Contessa JN; Rorrer WK; Chen PB
Oncogene; 1997 Sep; 15(10):1191-7. PubMed ID: 9294612
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
